WHA 0.00% 48.7¢ wattle health australia limited

SAMR/CFDA Approval Processing, page-39

  1. 26,847 Posts.
    lightbulb Created with Sketch. 1841
    CEO is very optimistic, as he said, WHA expects to reach $250m gross revenue over next five years.

    Blend & Pack, jointly owned by Mason (80% of Blend & Pack; also lend $20m to WHA to fund CBDG JV).
    Blend & Pack, 20% owner also founder, has 5% interest in CBDG JV.
    Mason is a shareholder of WHA, also holds 4.7m options with exercise price of $1.60

    Blend & Pack has three SAMR/CFDA slots, first slot is given to WHA for cow infant formula, second one is given to WHA for goat infant formula. I expect the third slot is also given to WHA for organic infant formula.
    Blend & Pack manufactured Bellamy’s infant formula (hasn’t checked if still manufacturing Bellamy’s as BAL applied CFDA via their own CNCA facility), has annual capacity of 20 million tins.
 
watchlist Created with Sketch. Add WHA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.